CTOs on the Move

WellDyneRX

www.welldynerx.com

 
WellDyneRx is a full-service, national pharmacy benefit manager (PBM) that makes the little things matter for our clients, employees, partners, and members.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.welldynerx.com
  • 7472 S Tucson Way Ste 100
    Englewood, CO USA 80112
  • Phone: 303.793.9954

Executives

Name Title Contact Details
Markus Waite
SVP, Chief Information Officer Profile

Similar Companies

Sellers Dorsey

Sellers Dorsey is a Philadelphia, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Tillges Certified Orthotic Prothstetic

Tillges Certified Orthotic Prothstetic, Inc. is a Saint Paul, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Codman Square Health Center

The mission of Codman Square Health Center is to serve as a resource for improving the physical, mental and social well-being of the community. Codman Square Health Center is an award-winning, community-based, outpatient health care and multi-service center in the heart of Dorchester. We opened our doors in 1979 with a dream: to build the best urban community in America. With a holistic and partnership-oriented approach, we ensure access to quality health care and other supportive services through a highly successful integrated model.

St. Margaret's Hospital

St. Margaret's Hospital is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Spring Valley, IL. To find more information about St. Margaret's Hospital, please visit www.aboutsmh.org

PharmaBlock Sciences

PharmaBlock Sciences (Nanjing), Inc. is a leading innovative chemistry products and services provider throughout the pharmaceutical R&D process. Its core businesses include: a catalog of specially designed scaffolds and building blocks; custom synthesis; process development; manufacturing of key intermediates and RSMs; and FTE services. The company was listed on Shenzhen Exchange Stock in China on November 10, 2017. PharmaBlock has rapidly gained recognition for its outstanding capability in the design, synthesis, and supply of lab scale building blocks. Building on that success, the company acquired Shandong Diai Biotechnology Co., Ltd. as its pilot plant and manufacturing site in 2016, and is providing scale-up synthesis and manufacturing of key intermediates/RSMs. PharmaBlock is now committed to a more comprehensive and long-term service to valued customers.